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A B S T R A C T   
Snakebite envenoming remains a neglected tropical disease which poses severe health hazard, especially for the 
rural inhabitants in Africa. In Nigeria, vipers are responsible for the highest number of deaths. Hydrophilic 
interaction liquid chromatography coupled with LC-MS/MS was used to analyze the crude venoms of Echis 
ocellatus (Carpet viper) and Bitis arietans (Puff adder) in order to understand their venom proteomic identities. 
Results obtained revealed that gel-free proteomic analysis of the crude venoms led to the identification of 85 and 
79 proteins, respectively. Seventy-eight (78) proteins were common between the two snake species with a 91.8% 
similarity score. The identified proteins belong to 18 protein families in E. ocellatus and 14 protein families in 
B. arietans. Serine proteases (22.31%) and metalloproteinases (21.06%) were the dominant proteins in the venom 
of B. arietans; while metalloproteinases (34.84%), phospholipase A2s (21.19%) and serine proteases (15.50%) 
represent the major toxins in the E. ocellatus venom. Other protein families such as three-finger toxins and 
cysteine-rich venom proteins were detected in low proportions. This study provides an insight into the venom 
proteomic analysis of the two Nigerian viper species, which could be useful in identifying the toxin families to be 
neutralized in case of envenomation.   
1. Introduction 
Venomous snakes pose severe health problems especially for the 
rural dwellers in the tropical regions of developing countries [1–3]. 
Despite the remarkable efforts for effective management of envenom-
ings, the World Health Organization (WHO) incorporated snakebite in 
the list of neglected tropical diseases [4]. Thus, further and better efforts 
are required to address the life-threatening situation posed by this dis-
ease. Snakebites are a common health hazard in the Savanna region of 
West Africa [2–4]. In Nigeria, the Viperidae, notably Bitis arietans (Puff 
adder) and Echis ocellatus (Carpet viper) are associated with the highest 
incidence of morbidity and mortality [1,5–7] and are regarded as the 
most dangerous venomous snake species. The actual fatality index 
resulting from envenomings by these vipers remains unknown due to 
inaccurate epidemiological data [1,2,8], as most of the victims do not 
have access to health care facilities and therefore resort to 
ethno-medicinal means for treatments. Reports from community-based 
surveys suggest a higher envenomation incidence than the 
hospital-based estimates [2,8,9]. The WHO reported about 5.4 million 
incidences of snakebites annually, with 2.7 million cases of envenom-
ings, 138,000 deaths and 400,000 cases of disabilities [10]. In Nigeria, 
the incidence of snakebites leads to 10,000 deaths annually where en-
venomation by E. ocellatus was responsible for 66% of total cases [7,11]. 
Snakebite inflicts severe damage to different organs of the body, and 
envenomings by the Viperidae are characterized by life-threatening 
symptoms, primarily due to local tissue damage and bleeding [1]. 
The evolution of venomics and antivenomics using the ‘-omics’ 
technologies has paved a way to obtain valuable insights into snake 
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venom compositions, revealing the protein constituents and different 
types of toxic components [12,13]. In addition, the ‘-omics’ approach 
has led to the rapid examination of the immune reactivity of antivenoms 
against the toxins found in snake venoms [2,14]. Due to the complex 
nature of the protein mixture in snake venoms, envenomation is char-
acterized by varied pathological manifestations [2]. It is reported that 
geographical inhabitation of snake [15–18], diet type [19] and age [20] 
contribute to the variability of the venom composition. Hence, analyzing 
venom proteomes to gain an insight into snake venom compositions can 
help in understanding their biological and pathological effects [21]. It 
will also help in making appropriate choice of antivenom to use in 
treatment. The venom gland transcriptomic of Nigerian B. arietans and 
E. ocellatus was reported previously [22,23]. In the current study, the 
venom proteomes of B. arietans and E. ocellatus captured from different 
regions of Nigeria were analyzed with the view to understanding their 
toxin profile and protein identities. 
2. Materials and method 
2.1. Bitis arietans and Echis ocellatus venom samples 
For this study, 42 male snakes (36 E. ocellatus and 6 B. arietans) were 
used. All protocols for snake handling were observed and carried out in 
accordance with the Ahmadu Bello University Committee on Animal Use 
and Care and in compliance with the revised ARRIVE guidelines 2.0. 
Adult snakes B. arietans and E. ocellatus were captured from different 
regions of the Southern and Northern parts of Nigeria. This sampling 
strategy justifies a generalized inference about the protein profile of 
these Nigerian vipers. The snakes were maintained at the serpentarium 
of the Department of Veterinary Pharmacology and Toxicology of 
Ahmadu Bello University. After 3 days, their venoms were manually 
extracted as described by Hill and Mackessy [24]. Venoms from snakes 
of the same species were combined. They were frozen at − 80 ◦C, 
lyophilized using a freeze-dryer, and stored at − 20 ◦C. 
2.2. Chemicals and reagents 
Magnetic bead-based hydrophilic interaction liquid chromatography 
(HILIC) particles were purchased from Sigma Aldrich (USA), whereas 
the protein standard marker and analytical-grade trypsin were obtained 
from Agilent Technologies (Santa Clara, CA, USA). 
2.3. Venom protein extraction and pellet solubilization 
The venom proteins were extracted following a method described 
previously [25]. Two milligrams (dry-weight) of the lyophilized crude 
venom (from each species) were solubilized in 50 μL 1 × PBS (pH 7.4), 
vortexed for 10 min, and centrifuged at 15,700×g for 5 min at 4 ◦C. 
Acetone precipitation was performed on the supernatant by the addition 
of 600 μL cold acetone, and the samples were incubated at − 20 ◦C for 15 
min. Precipitated samples were centrifuged at 15,700×g for 15 min at 
4 ◦C. Protein pellets were air-dried and resuspended in 100 μL 1 × PBS 
buffer (pH 7.4). Protein concentration of each sample was quantified 
using the RC DC Protein Assay Kit 11 (Bio-Rad Laboratories) and 
confirmed with the microvolume protein concentration determination 
method. Data was acquired on a Nanodrop Spectrophotometer 2000c 
(Thermo Fisher Scientific, USA). 
2.4. One-dimensional SDS-PAGE 
Aliquots of each sample (15 μg) were subjected to 12% SDS-PAGE 
under non-reducing conditions and ran for 90 min at 100 V. The gels 
were stained with Coomassie Brilliant Blue (G-250), and de-stained in 
10% glacial acetic acid containing 1% glycerol. The resolved protein 
bands were visualized using a Molecular Imager PharosFX Plus System 
(Bio-Rad, California, USA). 
2.5. Hydrophilic interaction liquid chromatography (HILIC) and trypsin 
digestion 
HILIC was carried out as described previously [25]. Fifty micrograms 
(50 μg) of protein from each venom sample was suspended in a final 
concentration of 50 mM triethylammonium bicarbonate (TEAB; Sigma). 
The proteins were reduced with a final concentration of 10 mM 
Dithiothreitol (DTT; Sigma) in 50 mM TEAB for 40 min at 56 ◦C. Samples 
were cooled to room temperature and alkylated with 30 mM iodoace-
tamide (Sigma) in 50 mM TEAB at 25 ◦C and the mixture was kept in the 
dark for 30 min. After alkylation, two-fold dilutions of the samples were 
made with a binding buffer (100 mM ammonium acetate, 30% aceto-
nitrile, pH 4.5). The protein solution was added to pre-equilibrated 
MagResyn® HILIC magnetic particles (Resyn Biosciences) prepared ac-
cording to the manufacturer’s instructions and incubated overnight at 
4 ◦C. After binding, the supernatant was removed and the magnetic 
particles were washed twice with 95% acetonitrile for 1 min. Thereafter, 
the magnetic particles were suspended in 50 mM ammonium formate 
(pH 8.0) containing trypsin (Promega) to a final enzyme: protein ratio of 
1:10 and the content was incubated overnight at 27 ◦C with constant 
shaking. Following the digestion, peptides were recovered with 1% 
trifluoroacetic acid (TFA); which were then incubated at room temper-
ature for 3 min and analyzed using liquid chromatography with tandem 
mass spectrometry (LC-MS/MS). 
Fig. 1. One-dimensional SDS-PAGE profile of B. arietans and 
E. ocellatus venoms. 
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2.6. Characterization of venom proteins 
Liquid chromatography was performed as described by Lomonte 
et al. [26] with slight modifications using an UltiMate™ 3000 RSLCnano 
System (Thermo Fisher Scientific, USA) equipped with a C18 trap column 
(5 mm × 300 μm; Thermo Fisher Scientific) and a CSH C18 analytical 
column (1.7 μm, 25 cm × 75 μm), with a linear gradient of 0.1% tri-
fluoroacetic acid in water (solution A) and acetonitrile (solution B). The 
samples were loaded on the trap column and the flow rate was set at 250 
nL/min and the gradient was generated as follows: 5–35% solution B for 
60 min and 35–50% solution B for 60–75 min. Chromatography was 
performed at 40 ◦C, and the outflow was delivered to the mass spec-
trometer through a stainless-steel nano-bore emitter. LC-MS analysis 
was performed on a Fusion mass spectrometer (Thermo Scientific, San 
Jose, CA) equipped with a nanospray ion source (Nanospray Flex™ Ion 
Sources, Thermo Fisher Scientific) coupled to a Dionex Ultimate 3000 
RSLC nano-HPLC system. Peptides recovered from the on-bead HILIC 
digestion for each venom sample was introduced through a 
stainless-steel emitter. Data were collected in positive mode with a spray 
voltage and ion transfer capillary set at 1.8 kV and 280 ◦C respectively. 
Spectra were internally calibrated using polysiloxane ions at m/z 
445.12003 and 371.10024. The first MS scan was performed using the 
orbitrap detector at 120,000 resolutions over an m/z range of 350–1650 
with an AGC target at 3E5 and maximum injection time of 40 ms. Data 
were acquired in profile mode. The second MS scan was performed using 
monoisotopic precursor selection for the ion with charges of +2 to +7 
with error tolerance set at ±10 ppm. Precursor ions were excluded for 
60 s after fragmentation. Precursor ions were selected for fragmentation 
in the HCD mode using the quadrupole mass analyzer with HCD energy 
set to 30%. Fragment ions were detected in the orbitrap mass analyzer at 
a resolution of 30000. The AGC target was set to 5E4 and the maximum 
injection time was set to 80 ms. Data were acquired in centroid mode. 
2.7. Data analysis 
The mass spectra obtained were subjected to analysis and processing 
using Proteome Discoverer v1.4 software (Thermo Fisher Scientific, 
USA) and the Sequest and Amanda algorithms, respectively. Database 
interrogation was performed against a concatenated database created by 
concatenating all ‘snake protein’ entries, including the previously 
analyzed transcriptome data of the two snakes in the Uniprot-Serpentes 
database with the cRAP contaminant database (https://www.thegpm. 
org/crap/). The precursor mass tolerance was set to 10 ppm and frag-
ment mass tolerance was set to 0.02 Da. Peptide validation was per-
formed using the Target-Decoy PSM validator node. The search results 
were subjected to Scaffold Q+ version 4.10.0 for further validation 
(www.proteomesoftware.com). Peptide identification, by peptide- 
spectrum match approach against UniProt-Serpentes database, and 
subsequent assembly, matching, and identification of protein sequences 
were performed using X! Tandem and Sequest search engines. The 
search engines were incorporated into Scaffold Q+, version 4.10.0 at 
99% protein threshold, 95% peptide threshold, and two-peptide mini-
mum criterion. The relative abundances (expressed as percentage of the 
total venom proteins) of the protein families were obtained by the 
unique spectral count strategy for label-free quantitative proteomics 
[27]. For accurate quantitation, Abacus computational tool for spectral 
Fig. 2. Relative distribution of protein families in the venom proteome of B. arietans.  
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counts was used to implement a distributed Normalized Spectral 
Abundance Factor (dNSAF), to accurately account for peptides shared 
across multiple proteins [28,29]. The mass spectrometric data has been 
deposited into the ProteomeXchange Consortium via the PRIDE [30] 
with an identifier PXD024638. 
3. Results and discussion 
3.1. One-dimensional SDS-PAGE of the crude snake venoms 
A fraction (15 μg) of each crude venom was size-fractionated on a 
one-dimensional SDS polyacrylamide gel and visualized using Coo-
massie Brilliant Blue R-250 dye (Fig. 1). The protein bands observed for 
the two venoms were distinctly different and clearly separated within 
the molecular weight ranges of 7 kDa, 22 kDa and 100 kDa (Fig. 1). The 
distinct pattern on the 1D gel correlated with the LC-MS/MS analysis 
which showed that B. arietans had serine proteases and metal-
loproteinases as the most abundant venom proteins (Fig. 2), while the 
venom of E. ocellatus was composed of three major protein families; i.e. 
metalloproteinases, phospholipase A2s, and serine proteases (Fig. 3). 
3.2. Snake venom proteomic characterization using LC-MS/MS 
Annotation was against the comprehensive UniProt Serpentes data-
base where all curated data are available, including the venom gland 
transcriptome dataset of Nigerian E. ocellatus and B. arietans. A total of 
79 proteins were detected in the venom of B. arietans whereas 85 pro-
teins were detected in the venom of E. ocellatus (Table 1) when the 
digested crude venom was analyzed using LC-MS/MS. Table 2 summa-
rizes the difference and similarities of the protein and protein families. 
These vipers shared a total of 78 proteins and 14 protein families in 
common. In addition, E. ocellatus had 4 protein families namely; phos-
pholipase A2 inhibitors, snake venom glutaminyl cyclases, secretary 
phospholipase A2 receptors and globin exclusive to its venom (Table 2). 
Overall, the protein similarity index was found to be 91.8%. Thus, all the 
proteins detected (in the molecular mass range of 4–93 kDa) (Table 3) 
belonged to 14 protein families in B. arietans and 18 protein families in 
E. ocellatus (Table 2). The most abundant proteins in the venom of 
B. arietans were serine proteases (22%) and metalloproteases (21%) 
(Fig. 2), followed by C-type lectins/snaclecs (10.65%), phospholipase A2 
(10.6%), L-amino acid oxidases (8.72%) and vascular endothelial 
growth factors (8.14%). Three-finger toxins (3.35%), disintegrins 
(3.4%), 5′-nucleotidases (2.5%), venom nerve growth factor (2.16%) 
and cysteine-rich venom proteins (2.05%) were found in relatively low 
abundance. Kunitz-type peptides, peroxiredoxin and phospholipase B 
were the least abundant protein families (<1%) identified in B. arietans 
(Fig. 2). On the other hand, the most abundant proteins identified in the 
venom of E. ocellatus include metalloproteinases (34.84%), phospholi-
pase A2 (21.19%), and serine proteases (15.05%) (Fig. 3). C-type lectins/ 
snaclecs (3.95%), three-finger toxins (2.16%), vascular endothelial 
growth factors (2.67%), cysteine-rich venom proteins (2.9%) and 
phospholipase A2 inhibitors (2.64%) were found in much lower 
Fig. 3. Relative distribution of protein families in the venom proteome of E. ocellatus.  
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Table 1 
Protein identification in the venoms of B. arietans and E. ocellatus.  
Protein/peptide detected  
S/ 
no. 
Echis ocellatus Originating species Bitis arietans Originating species 
1 Acidic phospholipase A2 Echis ocellatus Acidic phospholipase A2 Echis ocellatus 
2 Acidic phospholipase A2 Naja mossambica Acidic phospholipase A2 Naja mossambica 
3 Alpha-fibrinogenase Macrovipera lebetina Alpha-fibrinogenase Macrovipera lebetina 
4 Alpha-fibrinogenase-like Daboia siamensis Alpha-fibrinogenase-like Daboia siamensis 
5 Beta-fibrinogenase brevinase Gloydius blomhoffii Beta-fibrinogenase brevinase Gloydius blomhoffii 
6 C-type lectin 1 Bitis gabonica C-type lectin 1 Bitis gabonica 
7 Cationic trypsin Bos taurus Cationic trypsin Bos taurus 
8 Coagulation factor X-activating enzyme heavy chain Daboia siamensis Coagulation factor X-activating enzyme heavy chain Daboia siamensis 
9 Coagulation factor X-activating enzyme heavy chain Macrovipera lebetina Coagulation factor X-activating enzyme heavy chain Macrovipera lebetina 
10 Cysteine-rich venom protein Trimeresurus stejnegeri Cysteine-rich venom protein Trimeresurus stejnegeri 
11 Cytotoxin 1 Naja mossambica Cytotoxin 1 Naja mossambica 
12 Disintegrin EO5A Echis ocellatus Disintegrin EO5A Echis ocellatus 
13 Disintegrin bitistatin Bitis arietans Disintegrin bitistatin Bitis arietans 
14 Glutaminyl-peptide cyclotransferase Boiga dendrophila Kunitz-type serine protease inhibitor bitisilin-1 Bitis gabonica 
15 Hemoglobin subunit beta Erythrolamprus miliaris Kunitz-type serine protease inhibitor bitisilin-3 Bitis gabonica 
16 Kunitz-type serine protease inhibitor bitisilin-1 Bitis gabonica L-amino-acid oxidase Bitis gabonica 
17 Kunitz-type serine protease inhibitor bitisilin-3 Bitis gabonica L-amino-acid oxidase Echis ocellatus 
18 L-amino-acid oxidase Bitis gabonica L-amino-acid oxidase Pseudechis australis 
19 L-amino-acid oxidase Echis ocellatus Long neurotoxin 1 Naja anchietae 
20 L-amino-acid oxidase Pseudechis australis Peroxiredoxin-4 Crotalus atrox 
21 Long neurotoxin 1 Naja anchietae Phospholipase A2 homolog Echis ocellatus 
22 Peroxiredoxin-4 Crotalus atrox Phospholipase-B 81 Drysdalia coronoides 
23 Phospholipase A2 homolog Echis ocellatus Serine protease harobin Hydrophis hardwickii 
24 Phospholipase A2 inhibitor 1 Protobothrops flavoviridis Serine protease sp-Eoc49 Echis ocellatus 
25 Phospholipase-B 81 Drysdalia coronoides Short neurotoxin 1 Naja nivea 
26 Secretory phospholipase A2 receptor Pongo abelii Snaclec 2 Bitis gabonica 
27 Serine protease harobin Hydrophis hardwickii Snaclec 3 Bitis gabonica 
28 Serine protease sp-Eoc49 Echis ocellatus Snaclec agglucetin subunit beta-1 Deinagkistrodon acutus 
29 Short neurotoxin 1 Naja nivea Snaclec bitiscetin subunit alpha Bitis arietans 
30 Snaclec 2 Bitis gabonica Snaclec bitiscetin subunit beta Bitis arietans 
31 Snaclec 3 Bitis gabonica Snaclec clone 2100755 Deinagkistrodon acutus 
32 Snaclec CTL-Eoc124 Echis ocellatus Snake venom 5′-nucleotidase Crotalus adamanteus 
33 Snaclec CTL-Eoc125 Echis ocellatus Snake venom metalloproteinase ACLH Agkistrodon contortrix 
laticinctus 
34 Snaclec agglucetin subunit beta-1 Deinagkistrodon acutus Snake venom metalloproteinase kistomin Calloselasma rhodostoma 
35 Snaclec bitiscetin subunit alpha Bitis arietans Snake venom metalloproteinase lebetase-4 Macrovipera lebetina 
36 Snaclec bitiscetin subunit beta Bitis arietans Snake venom metalloproteinase-disintegrin-like 
mocarhagin 
Naja mossambica 
37 Snaclec clone 2100755 Deinagkistrodon acutus Snake venom serine protease BthaTL Bothrops alternatus 
38 Snaclec convulxin subunit beta Crotalus durissus terrificus Snake venom serine protease HS114 Bothrops jararaca 
39 Snake venom 5′-nucleotidase Crotalus adamanteus Snake venom serine protease NaSP Naja atra 
40 Snake venom metalloproteinase ACLH Agkistrodon contortrix 
laticinctus 
Snake venom serine protease Philodryas olfersii 
41 Snake venom metalloproteinase kistomin Calloselasma rhodostoma Snake venom vascular endothelial growth factor 
toxin barietin 
Bitis arietans 
42 Snake venom metalloproteinase lebetase-4 Macrovipera lebetina Thrombin-like enzyme cerastocytin Cerastes cerastes 
43 Snake venom metalloproteinase-disintegrin-like 
mocarhagin 
Naja mossambica Vascular endothelial growth factor A Bitis gabonica 
44 Snake venom serine protease BthaTL Bothrops alternatus Venom nerve growth factor 2 Naja sputatrix 
45 Snake venom serine protease HS114 Bothrops jararaca Weak neurotoxin 7 Naja naja 
46 Snake venom serine protease NaSP Naja atra Weak toxin CM-2a Naja annulifera 
47 Snake venom serine protease Philodryas olfersii Zinc metalloproteinase homolog-disintegrin 
albolatin 
Trimeresurus albolabris 
48 Snake venom vascular endothelial growth factor 
toxin barietin 
Bitis arietans Zinc metalloproteinase leucurolysin-B Bothrops leucurus 
49 Thrombin-like enzyme cerastocytin Cerastes cerastes Zinc metalloproteinase-disintegrin BA-5A Bitis arietans 
50 Venom nerve growth factor 2 Naja sputatrix Zinc metalloproteinase-disintegrin BlatH1 Bothriechis lateralis 
51 Weak neurotoxin 7 Naja naja Zinc metalloproteinase-disintegrin bilitoxin-1 Agkistrodon bilineatus 
52 Weak toxin CM-2a Naja annulifera Zinc metalloproteinase-disintegrin-like BfMP Bungarus fasciatus 
53 Zinc metalloproteinase homolog-disintegrin 
albolatin 
Trimeresurus albolabris Zinc metalloproteinase-disintegrin-like EoMP06 Echis ocellatus 
54 Zinc metalloproteinase leucurolysin-B Bothrops leucurus Zinc metalloproteinase-disintegrin-like EoVMP2 Echis ocellatus 
55 Zinc metalloproteinase-disintegrin BA-5A Bitis arietans Zinc metalloproteinase-disintegrin-like Eoc1 Echis ocellatus 
56 Zinc metalloproteinase-disintegrin BlatH1 Bothriechis lateralis Zinc metalloproteinase-disintegrin-like HF3 Bothrops jararaca 
57 Zinc metalloproteinase-disintegrin bilitoxin-1 Agkistrodon bilineatus Zinc metalloproteinase-disintegrin-like MTP9 Drysdalia coronoides 
58 Zinc metalloproteinase-disintegrin-like BfMP Bungarus fasciatus Zinc metalloproteinase-disintegrin-like NaMP Naja atra 
59 Zinc metalloproteinase-disintegrin-like EoMP06 Echis ocellatus Zinc metalloproteinase-disintegrin-like Cerberus rynchops 
60 Zinc metalloproteinase-disintegrin-like EoVMP2 Echis ocellatus Zinc metalloproteinase-disintegrin-like TSV-DM Trimeresurus stejnegeri 
61 Zinc metalloproteinase-disintegrin-like Eoc1 Echis ocellatus Zinc metalloproteinase-disintegrin-like VLAIP-A Macrovipera lebetina 
62 Zinc metalloproteinase-disintegrin-like HF3 Bothrops jararaca Zinc metalloproteinase-disintegrin-like VLAIP-B Macrovipera lebetina 
63 Zinc metalloproteinase-disintegrin-like MTP9 Drysdalia coronoides Zinc metalloproteinase-disintegrin-like acurhagin Deinagkistrodon acutus 
64 Zinc metalloproteinase-disintegrin-like NaMP Naja atra Zinc metalloproteinase-disintegrin-like atrolysin-A Crotalus atrox 
(continued on next page) 
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abundance. Disintegrins, 5′-nucleotidases, L-amino acid oxidases, snake 
venom glutaminyl cyclases, secretary phospholipase A2 receptors and 
Kunitz-type peptides families were very low in abundance (<3%), while 
phospholipase B, globin and venom nerve growth factor were virtually 
absent with percentage abundance of <1%, as shown in Fig. 3. 
3.3. Relative distribution of the protein families 
Increase in the accuracy of spectral count quantitation emerged 
following the advancements in bioinformatics tools [31]. As a general 
rule in spectral count, the number of spectra associated with a peptide 
shared by different proteins is used for computing spectral count of each 
protein with similar peptide. This has a limitation of introducing inac-
curacy in the estimation of protein abundances, in that if one or more 
peptides are shared between high and low-abundant proteins, the pro-
portion of the low-abundant protein tends to be overestimated [32]. This 
limitation was circumvented by implementing the distributed Normal-
ized Spectral Abundance Factor (dNSAF), where shared spectrum count 
is distributed based on the relative proportions of unique spectra 
assigned to the proteins containing the shared peptides [28]. Thus, 
Abacus software was used so as to extract and adjust the spectral counts 
from MS/MS data sets to accurately account for peptides shared across 
multiple proteins, through normalization steps [29]. In principle, the 
composition of the analyzed venoms indicated that metalloproteinases 
(SVMPs), serine proteinases (SVSPs), and phospholipases A2 (PLA2s) 
constituted the major proportions of the venom proteomes, which is 
consistent with the report of previous studies on viper venomics [16,33, 
34]. However, a deep insight into the proportion of these major protein 
families revealed a significant variation among species from different 
regions of the world; the protein composition of the venoms from vipers 
indigenous to Gaboon in West Africa showed that the percentages of 
PLA2s, SVSPs and SVMPs in B. arietans were 4.3%, 19.5% and 38.5% 
respectively [34]. More so, PLA2s, and SVMPs were the major toxin 
families, with varied proportions in the venoms of Echis species [35]. In 
the venoms of these vipers, indigenous to Nigeria, the percentages were 
higher; with PLA2s, SVSPs and SVMPs having 10.6%, 22.31%, and 
21.06% respectively in B. arietans while in E. ocellatus, 21.19%, 15.50% 
and 34.84% were recorded in PLA2s, SVSPs and SVMPs respectively 
(Figs. 2 and 3). These variations are attributed to factors such as snake’s 
gender, age [20], geographical origin [15–18] and diet [19]. It is 
believed that mutations in the venom-related genes may affect the 
venom composition [25]. Fifteen secondary protein families (Table 4) 
were detected, namely, kunitz-type peptides, cysteine-rich venom pro-
teins, three-finger toxins, disintegrins, L-amino acid oxidases, C-type 
lectins/snaclecs, 5’nucleotidases, vascular endothelial growth factors, 
phospholipase B, peroxiredoxin, phospholipase A2 inhibitors, snake 
venom glutaminyl cyclases, globin, secretory phospholipase A2 re-
ceptors, and venom nerve growth factors, with a distribution range be-
tween ⁓1% and 4% (Figs. 2 and 3). 
Casewell et al. [22] showed a transcriptomic analysis of venom gland 
where snake venom metalloproteinases and serine proteases were the 
major toxin genes transcribed in Nigerian B. arietans, and were also 
found to be the most abundant toxin family secreted in the venom [22]. 
This is in tandem with our findings that SVSPs and SVMPs were the 
Table 1 (continued ) 
Protein/peptide detected  
S/ 
no. 
Echis ocellatus Originating species Bitis arietans Originating species 
65 Zinc metalloproteinase-disintegrin-like Cerberus rynchops Zinc metalloproteinase-disintegrin-like batroxstatin- 
1 
Bothrops atrox 
66 Zinc metalloproteinase-disintegrin-like TSV-DM Trimeresurus stejnegeri Zinc metalloproteinase-disintegrin-like batroxstatin- 
3 
Bothrops atrox 
67 Zinc metalloproteinase-disintegrin-like VLAIP-A Macrovipera lebetina Zinc metalloproteinase-disintegrin-like 
berythractivase 
Bothrops erythromelas 
68 Zinc metalloproteinase-disintegrin-like VLAIP-B Macrovipera lebetina Zinc metalloproteinase-disintegrin-like bothrojarin- 
2 
Bothrops jararaca 
69 Zinc metalloproteinase-disintegrin-like acurhagin Deinagkistrodon acutus Zinc metalloproteinase-disintegrin-like brevilysin 
H2a 
Gloydius brevicaudus 
70 Zinc metalloproteinase-disintegrin-like atrolysin-A Crotalus atrox Zinc metalloproteinase-disintegrin-like cobrin Naja kaouthia 
71 Zinc metalloproteinase-disintegrin-like batroxstatin- 
1 
Bothrops atrox Zinc metalloproteinase-disintegrin-like daborhagin- 
K 
Daboia russelii 
72 Zinc metalloproteinase-disintegrin-like batroxstatin- 
3 
Bothrops atrox Zinc metalloproteinase-disintegrin-like stejnihagin- 
A 
Trimeresurus stejnegeri 
73 Zinc metalloproteinase-disintegrin-like 
berythractivase 
Bothrops erythromelas Zinc metalloproteinase-disintegrin-like stejnihagin- 
B 
Trimeresurus stejnegeri 
74 Zinc metalloproteinase-disintegrin-like bothrojarin- 
2 
Bothrops jararaca Zinc metalloproteinase/disintegrin Protobothrops 
mucrosquamatus 
75 Zinc metalloproteinase-disintegrin-like brevilysin 
H2a 
Gloydius brevicaudus Zinc metalloproteinase/disintegrin Trimeresurus gramineus 
76 Zinc metalloproteinase-disintegrin-like cobrin Naja kaouthia Zinc metalloproteinase/disintegrin Calloselasma rhodostoma 
77 Zinc metalloproteinase-disintegrin-like daborhagin- 
K 
Daboia russelii Metalloproteinase/disintegrin Echis ocellatus 
78 Zinc metalloproteinase-disintegrin-like stejnihagin- 
A 
Trimeresurus stejnegeri Zinc metalloproteinase/disintegrin Macrovipera lebetina 
79 Zinc metalloproteinase-disintegrin-like stejnihagin- 
B 
Trimeresurus stejnegeri Zinc metalloproteinase/disintegrin PMMP-1 Protobothrops 
mucrosquamatus 
80 Zinc metalloproteinase/disintegrin Protobothrops 
mucrosquamatus   
81 Zinc metalloproteinase/disintegrin Trimeresurus gramineus   
82 Zinc metalloproteinase/disintegrin Calloselasma rhodostoma   
83 Metalloproteinase/disintegrin Echis ocellatus   
84 Zinc metalloproteinase/disintegrin Macrovipera lebetina   
85 Zinc metalloproteinase/disintegrin PMMP-1 Protobothrops 
mucrosquamatus   
Proteins were identified using Multi-Dimensional Protein Identification Technology (MuDPIT) incorporated on Scaffold Proteome software version 4.10.0 at 99% 
protein threshold, 95% peptide threshold, 0.5% false discovery rate (FDR), and two-peptide minimum criterion. Peptides and proteins were searched against the 
UniprotKB- Serpentes-database. 
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dominant proteins in the venom of B. arietans. Similarly, snake venom 
metalloproteinases, phospholipase A2 and serine proteases constituted 
the most abundant toxin genes transcribed in the venom glands of 
E. ocellatus from Nigeria [23]. The abundance of these 3 toxin families 
(PLA2s, SVSPs and SVMPs) in the venom gland transcriptomic analyses 
correlates with the findings of this study. In a parallel comparison, the 
transcriptomic analyses showed that C-type lectins and L-amino oxidases 
were present in high abundances but in this study, they are present in 
low abundances 3.95% and 2.24% respectively in the venom proteome 
(Fig. 3). This disparity may be due to the fact that toxins are known to be 
transcribed at the highest level in the venom gland [22]. 
3.4. Pathological mechanisms of the toxin families 
Snake venom toxins are thought to act synergistically in exerting a 
wide range of biochemical and toxicological effects [36,37]. Envenom-
ation by the viper primarily gives rise to local effects and bleeding [38, 
39]. Snake venom metalloproteinases (SVMPs) are zinc-dependent 
proteinase toxins that are responsible for many of the generally known 
pathological phenotypes in envenomation by the viper snake species 
[16,40–42] and play a key role in coagulopathies commonly associated 
with viper envenoming [40,41,43]. Similarly, SVMPs provoke a mani-
fold of clinical manifestations, including hemorrhagic, pro-coagulant, 
anticoagulant, fibrinolytic, apoptotic, and antiplatelet activities [44, 
45]. Thus, SVMPs are believed to evolve from ADAM (a Disintegrin and 
Metalloproteinase) proteins, precisely ADAM28, characterized by met-
alloproteinase, disintegrin-like and cysteine-rich domains [46], which 
induce hemorrhagic activity by rupturing the capillary vessels, resulting 
to extravasation in envenomed victims [47]. This occurs through 
cleavage of the basement membrane and adhesion proteins of the 
endothelial cells-matrix, causing the endothelial cells to detach and 
become thin, leading to the obstruction of the capillary walls and blood 
effusion [40,48]. More so, SVMPs alters homeostasis by disrupting 
coagulation, through modulation of fibrinogenase and fibrolase that 
mediate the coagulation cascade which aids in eliciting their hemor-
rhagic role [49,50]. The venom of the viper snakes contained the three 
related structural classes of SVMPs, protein-type I, II and III. The P–I 
class has only a metalloproteinase domain, P-II class consists of a met-
alloproteinase and disintegrin domain, whereas the P-III class has a 
metalloproteinase domain, a disintegrin-like domain and a cysteine-rich 
domain. Among the protein-type I snake venom metalloproteinases, 
kistomin impairs platelet function by binding and cleaving of both 
platelet membrane glycoprotein Ib and glycoprotein VI [51]. ACLH 
exerts fibrinogenolytic and fibrinolytic effects [52], acurhagin prefer-
entially cleaves Alpha chain of fibrinogen, followed by Beta chain, with 
minimal effects on the gamma chains [53]. Bilitoxin-1 represents 
protein-type II hemorrhagic toxin isolated from the venom of these 
snakes [54]. The catalytic activity of protein-type III hemorrhagic 
leucurolysin-B on extracellular matrix proteins leads to loss of capillary 
integrity, resulting in hemorrhage with alterations in platelet function 
[55]. Atrolysin A is a potent inhibitor of platelet aggregation, the region 
of the disintegrin-like domain is primarily responsible for blocking 
platelet aggregation [56]. Berythractivase contains metalloproteinase, 
disintegrin-like and cysteine-rich domains. Structurally, berythractivase 
is similar to snake-venom haemorrhagic metalloproteinases and func-
tionally similar to group A prothrombin activators [57]. 
Snake venom serine proteinases (SVSPs) are multifunctional en-
zymes that induce toxicity in envenomed victims by affecting the he-
mostatic system. They alter blood coagulation processes, fibrinolysis 
and platelet aggregation [35,36,58]. 
In this study, the venom of E. ocellatus was found to be dominated by 
Phospholipases A2 (PLA2s) which constituted 21% of the venom prote-
ome. Our data correlates with the previous studies in which PLA2s were 
described as one of the commonest toxins in the venom of the front- 
fanged snakes [59,60]. Although PLA2s were present in both venoms, 
it was found to be lower (10.6%) in the venom of B. arietans (Fig. 2). 
These toxins had molecular masses of 13 and 16 kDa (Table 3) and are 
important cause of myotoxic effect of viper envenomation [61,62], 
which often leads to severe necrosis [63]. In addition, PLA2s from 
venoms of Viperidae snake family induce membranotropic effects [64, 
65]. 
Other toxin families identified in the venom of these vipers were 
three-finger toxins, kunitz-type peptides, cysteine-rich secretary pro-
teins, disintegrins, L-amino acid oxidases, C-type lectins, 5-nucleotidase, 
vascular endothelial growth factors and phospholipase B. These toxins 
were detected, albeit, at lower abundances in the venom of E. ocellatus 
(Fig. 3) compared to that of B. arietans (Fig. 2). The toxin 5′-nucleotid-
ases inhibit the aggregation of platelet through the release of adenosine 
from adenosine monophosphate which binds to receptors on the plate-
lets [66], this shows that they act in synergy with hemorrhagic toxins to 
elicit anticoagulant effect observed in snake bite envenoming [67,68]. 
L-amino acid oxidases (LAAOs) in snake venoms catalyze oxidative 
deamination of amino acids, leading to the release of hydrogen peroxide 
[69], which provokes toxicity by impacting on platelet aggregation and 
inducing hemorrhage that ultimately leads to apoptosis of vascular 
endothelial cells [70,71]. 
Additionally, the cysteine-rich venom proteins (CRISPs) are toxin 
families whose exact function in snake venoms is not known, they are 
however, potential blockers of Ca2+ and cyclic nucleotide-gated chan-
nels [72]. The C-type lectins/snaclecs (CTLs) are calcium-dependent 
non-enzymatic proteins that bind carbohydrates, mainly galactose 
[37] and play important roles in the agglutination of erythrocytes and 
aggregation of platelet [73]. 
Also, three-finger toxins (3FTXs) are non-enzymatic three-finger fold 
structure that is both neurotoxic and cytotoxic in nature [74]. 3FTXs are 
commonly found in the venoms of snakes from the Elapids family [16], 
they bind at the postsynaptic neuromuscular junctions, thereby inducing 
flaccid paralysis in victims [75]. Their biological activity in the venoms 
of Viperidae snake family needs to be explored [64]. However, their 
Table 2 
Summary of the proteins identified, presenting the similarities and differences of 
proteins and protein families.  
Protein family Number of proteins 




0 0 37 
Snake venom Serine proteases 0 0 13 
Phospholipase A2s 0 0 3 
Kunitz peptides 0 0 2 
Cysteine-rich venom protein 0 0 1 
Disintegrins 0 0 2 
L-amino acid oxidases 0 0 3 
Three-finger toxins 0 0 5 
C-type lectins/Snaclecs 0 3 7 
5′ Nucleotidases 0 0 1 
Vascular endothelial growth 
factors 
1 0 1 
Phospholipase B 0 0 1 
Peroxiredoxin 0 0 1 
Phospholipase A2 inhibitor 0 1 0 
Snake venom glutaminyl 
cyclases 
0 1 0 
Globin 0 1 0 
Secretory phospholipase A2 
receptor 
0 1 0 
Venom nerve growth factor 0 0 1 
Total 1 7 78 
The proteins identified were classified into 14 and 18 protein families in 
B. arietans and E. ocellatus respectively, with 78 proteins common to both 
venoms. There were 1 and 7 protein(s) exclusive to the venom of B. arietans and 
E. ocellatus respectively. E. ocellatus had additional 4 protein families (Phos-
pholipase A2 inhibitor, Snake venom glutaminyl cyclases, Globin and Secretary 
phospholipase A2 receptor) exclusive to its venom. 
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Table 3 
Characteristics of the proteins identified in the venom extracts of B. arietans and E. ocellatus.   
B. arietans E. ocellatus 
S/ 
No. 






NET TUSC EUP AA 
(%) 
NET TUSC EUP 
1 Acidic phospholipase A2 PA2A5_ECHOC 16 83 32 12 8 61 439 79 38 
2 Acidic phospholipase A2 PA2A1_NAJMO 13 39 19 1 1 39 9 1 1 
3 Alpha-fibrinogenase VSPA_MACLB 29 8.5 29 0 0 8.1 20 0 0 
4 Alpha-fibrinogenase-like VSPAF_DABSI 28 3.5 28 0 0 0.8 20 1 1 
5 Beta-fibrinogenase brevinase VSPB_GLOBL 26 8.6 54 0 0 16 76 2 1 
6 C-type lectin 1 LEC1_BITGA 19 16 4 2 2 8.2 2 1 1 
7 Cationic trypsin TRY1_BOVIN 26 16 5 3 3 8.5 2 1 1 
8 Coagulation factor X-activating enzyme heavy chain VM3CX_DABSI 70 8.1 33 0 0 21 43 9 4 
9 Coagulation factor X-activating enzyme heavy chain VM3CX_MACLB 69 8.5 14 0 0 18 54 4 3 
10 Cysteine-rich venom protein CRVP_TRIST 26 4.3 1 0 0 13 14 0 0 
11 Cytotoxin 1 3SA1_NAJMO 7 47 9 0 0 33 30 0 0 
12 Disintegrin EO5A DID5A_ECHOC 12 9.6 7 0 0 36 31 0 0 
13 Disintegrin bitistatin VM2_BITAR 9 88 80 11 6 27 6 12 6 
14 Glutaminyl-peptide cyclotransferase QPCT_BOIDE 42 0.0 0 0 0 17 12 1 1 
15 Hemoglobin subunit beta HBB_ERYML 16 0.0 0 0 0 6.2 3 1 1 
16 Kunitz-type serine protease inhibitor bitisilin-1 VKT1_BITGA 10 18 5 2 2 10 2 2 2 
17 Kunitz-type serine protease inhibitor bitisilin-3 VKT3_BITGA 17 42 12 5 4 17 7 2 2 
18 L-amino-acid oxidase OXLA_BITGA 7 12 4 0 0 20 7 1 1 
19 L-amino-acid oxidase OXLA_ECHOC 57 34 58 1 1 63 109 1 1 
20 L-amino-acid oxidase OXLA_PSEAU 59 1.4 2 0 0 6.2 8 0 0 
21 Long neurotoxin 1 3L21_NAJAC 8 90 60 6 2 93 64 11 5 
22 Peroxiredoxin-4 PRDX4_CROAT 4 58 4 2 2 31 2 1 1 
23 Phospholipase A2 homolog PA2HS_ECHOC 16 60 42 19 13 78 312 75 46 
24 Phospholipase A2 inhibitor 1 PLI1_PROFL 22 0.0 0 0 0 8.5 20 1 1 
25 Phospholipase-B 81 PLB_DRYCN 64 19 121 14 11 20 73 14 11 
26 Secretory phospholipase A2 receptor PLA2R_PONAB 18 0.0 0 0 0 1.2 3 1 1 
27 Serine protease harobin VSPHA_HYDHA 29 7.9 21 3 1 7.9 21 4 3 
28 Serine protease sp-Eoc49 VSP_ECHOC 28 24 27 4 4 49 51 18 13 
29 Short neurotoxin 1 3S11_NAJNI 7 61 8 0 0 66 17 2 2 
30 Snaclec 2 SL2_BITGA 18 35 26 6 5 31 18 7 6 
31 Snaclec 3 SL3_BITGA 18 18 7 3 2 24 9 4 2 
32 Snaclec CTL-Eoc124 SL124_ECHOC 17 0.0 0 0 0 65 33 14 9 
33 Snaclec CTL-Eoc125 SL125_ECHOC 18 0.0 0 0 0 47 11 6 6 
34 Snaclec agglucetin subunit beta-1 SLB1_DEIAC 17 9.6 2 0 0 9.6 4 0 0 
35 Snaclec bitiscetin subunit alpha SLA_BITAR 15 96 124 0 0 91 82 0 0 
36 Snaclec bitiscetin subunit beta SLB_BITAR 15 60 71 27 13 50 60 18 7 
37 Snaclec clone 2100755 SL_DEIAC 18 4.5 4 27 13 14 5 18 7 
38 Snaclec convulxin subunit beta SLB_CRODU 17 0.0 0 0 0 11 4 0 0 
39 Snake venom 5′-nucleotidase V5NTD_CROAD 65 39 43 11 5 30 52 5 3 
40 Snake venom metalloproteinase ACLH VM1AH_AGKCL 46 5.2 3 0 0 7.1 7 0 0 
41 Snake venom metalloproteinase kistomin VM1K_CALRH 47 5.3 10 0 0 2.9 4 0 0 
42 Snake venom metalloproteinase lebetase-4 VM1L4_MACLB 24 12 4 0 0 25 17 1 1 
43 Snake venom metalloproteinase-disintegrin-like 
mocarhagin 
VM3M1_NAJMO 68 2.0 30 4 2 4.4 18 5 2 
44 Snake venom serine protease BthaTL VSPTL_BOTAL 26 5.6 7 0 0 5.6 6 0 0 
45 Snake venom serine protease HS114 VSP14_BOTJA 28 5.4 1 0 0 5.4 3 0 0 
46 Snake venom serine protease NaSP VSP1_NAJAT 31 7.4 3 0 0 7.4 2 0 0 
47 Snake venom serine protease VSP_PHIOL 28 15 6 1 1 14 3 1 1 
48 Snake venom vascular endothelial growth factor 
toxin barietin 
TXVE_BITAR 17 55 302 30 15 59 107 24 13 
49 Thrombin-like enzyme cerastocytin VSPP_CERCE 28 13 67 4 3 13 48 3 3 
50 Venom nerve growth factor 2 NGFV2_NAJSP 27 13 10 0 0 18 10 0 0 
51 Weak neurotoxin 7 3NO27_NAJNA 8 5 2 1 1 12 9 0 0 
52 Weak toxin CM-2a 3SOK2_NAJHA 7 46 1 2 1 46 3 3 2 
53 Zinc metalloproteinase homolog-disintegrin 
albolatin 
VM2AL_TRIAB 54 5.4 13 2 1 12 13 1 1 
54 Zinc metalloproteinase leucurolysin-B VM3LB_BOTLC 36 13 8 1 1 18 26 1 1 
55 Zinc metalloproteinase-disintegrin BA-5A VM25A_BITAR 59 13 10 6 5 31 96 28 21 
56 Zinc metalloproteinase-disintegrin BlatH1 VM2H1_BOTLA 54 4.1 10 0 0 2.5 4 0 0 
57 Zinc metalloproteinase-disintegrin bilitoxin-1 VM2B1_AGKBI 32 13 8 3 2 10 6 3 2 
58 Zinc metalloproteinase-disintegrin-like BfMP VM3_BUNFA 68 1.3 4 0 0 3.8 7 0 0 
59 Zinc metalloproteinase-disintegrin-like EoMP06 VM3E6_ECHOC 58 17 21 6 4 92 165 28 17 
60 Zinc metalloproteinase-disintegrin-like EoVMP2 VM3E2_ECHOC 69 19 20 6 5 55 241 117 66 
61 Zinc metalloproteinase-disintegrin-like Eoc1 VM3E1_ECHOC 69 22 59 6 8 57 201 68 36 
62 Zinc metalloproteinase-disintegrin-like HF3 VM3H3_BOTJA 68 9.6 14 0 0 13 30 0 0 
63 Zinc metalloproteinase-disintegrin-like MTP9 VM39_DRYCN 68 1.3 4 0 0 5.4 8 0 0 
64 Zinc metalloproteinase-disintegrin-like NaMP VM3_NAJAT 69 3 5 1 1 1.6 2 1 1 
65 Zinc metalloproteinase-disintegrin-like VM3_CERRY 69 5.7 9 0 0 6.2 4 0 0 
66 Zinc metalloproteinase-disintegrin-like TSV-DM VM3TM_TRIST 69 8.2 12 0 0 6.8 7 0 0 
67 Zinc metalloproteinase-disintegrin-like VLAIP-A VM3VA_MACLB 69 19 58 7 6 22 92 10 7 
68 Zinc metalloproteinase-disintegrin-like VLAIP-B VM3VB_MACLB 69 14 37 2 2 11 38 2 1 
69 Zinc metalloproteinase-disintegrin-like acurhagin VM3AH_DEIAC 69 9.7 14 1 1 5.4 9 1 1 
(continued on next page) 
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relative proportion was found to be 3.35% and 2.16% in the venoms of 
B. arietans (Fig. 2) and E. ocellatus (Fig. 3) respectively. 
Disintegrins are venom toxins that were first detected in viper snakes 
[76], and are potent inhibitor of platelet aggregation, hence, antagonize 
the clotting of blood [77], thereby contributing to lethality in enve-
nomed victims. 
Moreover, snake venom vascular endothelial growth factors were 
distributed in minute quantities notably in the venom of E. ocellatus. 
They possess vasculotoxin-like activity which makes snakebite site liable 
to rapid infiltration of venom into victims [78]. In the case of kunitz-type 
peptides, a very low percentage (1%) in the venom of these vipers 
(Figs. 2 and 3) was obtained with molecular mass range of 10–17 kDa 
(Table 3). Phospholipase B (PLB) was among the least abundant proteins 
with 1.8% (Figs. 2) and 0.6% (Fig. 3) in the venoms of B. arietans and 
E. ocellatus respectively. In snake venomics analysis, much interest has 
not been given to PLB probably because the enzyme is not commonly 
identified in snake venoms [79], therefore, there are limited data on this 
enzyme, and hence, the exact pathological function of PLB in snake 
venom has not been explained. Several studies reported the presence of 
PLB in some viper venoms [79,80], which is in accord with our findings. 
4. Snake venom phospholipase A2 inhibitor 
It is known that phospholipase A2 is one of the venom toxins that 
cause the disorder associated with snakebite envenoming. Hence, 
inhibiting the lethal actions of snake venom Phospholipase A2 presents a 
strategic target for therapeutic interference [81]. Interestingly, Phos-
pholipase A2 inhibitor, a potential antitoxin with molecular mass of 22 
kDa was detected in the venom of E. ocellatus. Available literature re-
ports that the blood plasma of numerous snake species are naturally 
composed of endogenous phospholipase A2 inhibitors, generally known 
as snake blood phospholipase A2 inhibitors (sbPLIs). Primarily, they 
neutralize deleterious effects of phospholipase A2 [82,83]. It implies that 
sbPLIs exert self-protection role against the enzymes of their own 
venom, which eventually reach the circulatory system [82,83]. What 
seems new is the fact that phospholipase A2 inhibitory protein was 
detected in the venom, revealing that the protein is not only expressed in 
the snake blood serum. Exploring this promising protein may serve as 
antidote to PLA2-related disorders by giving rise to clinically relevant 
and specific antivenom that targets phospholipase A2. 
5. Conclusion 
In addition to the detection of a venom-based antitoxin; venom 
phospholipase A2 inhibitor, this study has provided a baseline infor-
mation on the venom proteome of E. ocellatus and B. arietans indigenous 
to Nigeria, where E. ocellatus producing more of the toxins. In both snake 
venoms, their protein profile was found to be 91.8% similar and SVMPs, 
PLA2s and SVSPs were the major toxin families. E. ocellatus had 34.84%, 
21.19% and 15.50% while in B. arietans, 22.31%, 21.06% and 10.6% 
were recorded for SVSPs, SVMPs and PLA2s respectively. Going by these 
findings, one can say that although the envenomation by these snakes 
may present some common pathogenic signs due to some similarities in 
the venom composition, their venoms are very much different when the 
toxins are taken into consideration and as such, this can serve as a guide 
in the use and design of a potential antivenom. 
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Table 3 (continued )  
B. arietans E. ocellatus 
S/ 
No. 






NET TUSC EUP AA 
(%) 
NET TUSC EUP 
70 Zinc metalloproteinase-disintegrin-like atrolysin-A VM3AA_CROAT 47 4.3 4 1 1 7.6 12 3 3 
71 Zinc metalloproteinase-disintegrin-like batroxstatin- 
1 
VM31_BOTAT 46 1.9 4 0 0 5.7 3 1 1 
72 Zinc metalloproteinase-disintegrin-like batroxstatin- 
3 
VM33_BOTAT 69 8 7 0 0 4.3 11 1 1 
73 Zinc metalloproteinase-disintegrin-like 
berythractivase 
VM3BE_BOTER 69 4.9 9 0 0 9 14 3 1 
74 Zinc metalloproteinase-disintegrin-like bothrojarin- 
2 
VM3B2_BOTJA 24 7.8 2 0 0 14 20 4 4 
75 Zinc metalloproteinase-disintegrin-like brevilysin 
H2a 
VM32A_GLOBR 47 6.4 6 0 0 11 29 0 0 
76 Zinc metalloproteinase-disintegrin-like cobrin VM3_NAJKA 68 4.7 2 1 1 8.2 5 2 2 
77 Zinc metalloproteinase-disintegrin-like daborhagin- 
K 
VM3DK_DABRR 70 7.3 5 2 2 15 34 5 5 
78 Zinc metalloproteinase-disintegrin-like stejnihagin-A VM3SA_TRIST 68 7.7 13 0 0 7.2 11 2 1 
79 Zinc metalloproteinase-disintegrin-like stejnihagin-B VM3SB_TRIST 68 7 11 0 0 8.3 13 0 0 
80 Zinc metalloproteinase/disintegrin VM2P3_PROMU 46 9.2 8 0 0 2.9 1 0 0 
81 Zinc metalloproteinase/disintegrin VM3G1_TRIGA 48 2.1 3 0 0 7.4 22 0 0 
82 Zinc metalloproteinase/disintegrin VM2RH_CALRH 54 12 16 0 0 6.3 13 2 1 
83 Metalloproteinase/disintegrin VM2OC_ECHOC 55 11 22 10 4 39 216 45 29 
84 Zinc metalloproteinase/disintegrin VM2L2_MACLB 53 13 17 0 0 17 2 4 2 
85 Zinc metalloproteinase/disintegrin PMMP-1 VM2P1_PROMU 53 7.9 13 0 0 9.8 11 1 1 
The characterization of proteins was achieved using Sequest and X!Tandem incorporated Scaffold Proteome Software 4.10.0: 2019/100. 
Abbreviation: Mol. mass: molecular mass, %AA: percentage of amino acids, NET: Number of estimated enzymatic cleavage, EUP: Exclusive unique Peptide, TUPC: 
Total Unique Protein Count. 
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the ProteomeXchange Consortium via the PRIDE26 partner repository 
with the dataset identifier PXD024638 and 10.6019/PXD024638, at 
https://www.ebi.ac.uk/pride/archive/projects/PXD024638. 
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Acidic phospholipase A2 
Phospholipase A2 homolog 
Phospholipase-B 81 Phospholipase B 




Coagulation factor X-activating enzyme heavy 
chain 
Coagulation factor X-activating enzyme heavy 
chain 
Serine protease harobin 
Serine protease sp-Eoc49 
Snake venom serine protease BthaTL 
Snake venom serine protease HS114 
Snake venom serine protease NaSP 
Snake venom serine protease 
Thrombin-like enzyme cerastocytin 
Kunitz-type serine protease inhibitor bitisilin-1 Kunitz peptides 
Kunitz-type serine protease inhibitor bitisilin-3 
Snake venom metalloproteinase ACLH Snake venom 
metalloproteinases Snake venom metalloproteinase kistomin 
Snake venom metalloproteinase lebetase-4 
Snake venom metalloproteinase-disintegrin-like 
mocarhagin 
Zinc metalloproteinase homolog-disintegrin 
albolatin 
Zinc metalloproteinase leucurolysin-B 
Zinc metalloproteinase-disintegrin BA-5A 
Zinc metalloproteinase-disintegrin BlatH1 
Zinc metalloproteinase-disintegrin bilitoxin-1 
Zinc metalloproteinase-disintegrin-like BfMP 
Zinc metalloproteinase-disintegrin-like EoMP06 
Zinc metalloproteinase-disintegrin-like EoVMP2 
Zinc metalloproteinase-disintegrin-like Eoc1 
Zinc metalloproteinase-disintegrin-like HF3 
Zinc metalloproteinase-disintegrin-like MTP9 
Zinc metalloproteinase-disintegrin-like NaMP 
Zinc metalloproteinase-disintegrin-like 
Zinc metalloproteinase-disintegrin-like TSV-DM 
Zinc metalloproteinase-disintegrin-like VLAIP-A 
Zinc metalloproteinase-disintegrin-like VLAIP-B 
Zinc metalloproteinase-disintegrin-like acurhagin 










Zinc metalloproteinase-disintegrin-like brevilysin 












Zinc metalloproteinase/disintegrin PMMP-1 
Cysteine-rich venom protein Cysteine-rich venom protein 
Disintegrin EO5A Disintegrins  
Table 4 (continued ) 
Proteins Protein families 
Disintegrin bitistatin 
L-amino-acid oxidase L-amino acid oxidases 
L-amino-acid oxidase 
L-amino-acid oxidase 
Long neurotoxin 1 Three-finger toxins 
Short neurotoxin 1 
Weak toxin CM-2a 
Cytotoxin 1 




Snaclec agglucetin subunit beta-1 
Snaclec bitiscetin subunit alpha 
Snaclec bitiscetin subunit beta 
Snaclec clone 2100755 
Snaclec convulxin subunit beta 
C-type lectin 1 
Snake venom 5′-nucleotidase 5′ Nucleotidases 
Snake venom vascular endothelial growth factor 
toxin barietin 
Vascular endothelial growth 
factors 
Vascular endothelial growth factor A 
Peroxiredoxin-4 Peroxiredoxin 
Phospholipase A2 inhibitor 1 Phospholipase A2 inhibitor 
Snake venom glutaminyl-peptide cyclotransferase Glutaminyl cyclases 
Hemoglobin subunit beta Globin 
Secretory phospholipase A2 receptor Phospholipase A2 receptor 
Venom nerve growth factor 2 Venom nerve growth factor  
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